New hope for fertility: drug may reverse early menopause in autoimmune patients
Disease control
Recruiting now
This study tests whether an immunomodulatory drug (rituximab) can improve or normalize ovarian function in women aged 18-38 with autoimmune premature ovarian insufficiency (POI). Participants receive either rituximab or a placebo, and those who respond may undergo IVF. The goal i…
Phase: PHASE3 • Sponsor: Angelica Lindén Hirschberg • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC